Back
Berkshire Hathaway, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Sell
49
BRK.A
Berkshire Hathaway, Inc.
Last Price:
$749,759.52
Seasonality Move:
6.5%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Sell
49
Berkshire Hathaway, Inc. (BRK.A)
is a Sell
Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?
-
The current Berkshire Hathaway, Inc. [BRK.A] share price is $750,300.00. The Score for BRK.A is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRK.A Stock Price Chart
What is Berkshire Hathaway, Inc.'s stock price today?
-
The Berkshire Hathaway, Inc. share price today is $750,300.00The current trend is relatively stagnant and BRK.A is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.
BRK.A Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -569.11 | Sell |
| Relative Strength Index (14 RSI): | 50.35 | Buy |
| Chaikin Money Flow: | 98 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 65.68 | Buy |
| Chaikin Money Flow: | -209678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BRK.A Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 749733.75 | Buy |
| 20-day SMA: | 749441.68 | Buy |
| 50-day SMA: | 748296.66 | Buy |
| 200-day SMA: | 746216.6 | Buy |
| 8-day EMA: | 748899.13 | Buy |
| 20-day EMA: | 749856.73 | Buy |
| 50-day EMA: | 748491.17 | Buy |
| 200-day EMA: | 736552.27 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.57 | Buy |
| 50-day SMA: | 45.67 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 48.35 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 40.28 | Buy |
Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates
-
Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $5,141.98 per share, and a decrease next year of $3,961.08 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
Berkshire Hathaway, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||